Intrathecal neurolysis for the management of refractory pain in a patient with terminal oncological disease: case report.

Pain Manag

Clínica Foscal International, Calle 158 # 20-95 Piso 3 Consultorio 304, Floridablanca, Santander, 681001, Colombia.

Published: July 2022

We report on the successful treatment of refractory cancer pain by intrathecal neurolysis using 96% absolute alcohol. A female patient with colorectal adenocarcinoma with metastases to the sacral bones, the patient had severe pain refractory to pharmacological and interventional treatment. Intrathecal neurolytic block at the L5-S1 intervertebral space was performed, she reported a significant improvement in her pain and decreased opioid use. The patient did not show deterioration of neurological functions after the procedure or associated complications, and outpatient treatment continued with a home medicine program. She remained comfortable until her death 6 weeks later. Considering that this is an accessible and cost-effective procedure, it could be a helpful alternative for the management of patients with refractory pain in the terminal stage.

Download full-text PDF

Source
http://dx.doi.org/10.2217/pmt-2021-0097DOI Listing

Publication Analysis

Top Keywords

intrathecal neurolysis
8
refractory pain
8
pain
5
neurolysis management
4
refractory
4
management refractory
4
patient
4
pain patient
4
patient terminal
4
terminal oncological
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!